Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Sunshine Guojian Pharmaceutical(688336) the Revenue is 434.47 M (+31.3%);the EBIT is 128.03 M (+174.5%);the EPS is 0.21 (+124.4%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.43B31.30%
----
----
EBIT
0.13B174.52%
----
----
EPS
0.2098124.36%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf